Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 0.5380
-0.0180 (-3.24%)
Nov 3, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 71.84 million as of November 3, 2026. It is the 43,053rd most valuable company in the world and the 636th biggest in Sweden. Its market cap has decreased by 82.32% in one year.
Market Cap
71.84M
Enterprise Value
34.29M
Revenue
n/a
Global Rank
Country Rank
#636 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 71.84M, a decrease of -87.22%. That is a compound annual growth rate of -23.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 71.84M | -82.39% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abera Bioscience AB | 140.62M |
| Initiator Pharma | 128.69M |
| Xintela AB | 128.33M |
| Active Biotech AB | 109.40M |
| Alzinova AB | 106.04M |
| Biovica International AB | 98.67M |
| OncoZenge AB | 83.36M |
| Pila Pharma AB | 71.95M |